tiprankstipranks
Advertisement
Advertisement
AdAlta Posts Landmark Long-Term Responses in Mesothelioma CAR-T Trial
PremiumCompany AnnouncementsAdAlta Posts Landmark Long-Term Responses in Mesothelioma CAR-T Trial
26d ago
AdAlta Advances EW-001 CAR-T Program and AI-Driven East-to-West Strategy
Premium
Company Announcements
AdAlta Advances EW-001 CAR-T Program and AI-Driven East-to-West Strategy
1M ago
AdAlta Seeks ASX Quotation for Major New Share and Option Issue
Premium
Company Announcements
AdAlta Seeks ASX Quotation for Major New Share and Option Issue
2M ago
AdAlta targets sophisticated investors with speculative ASX-listed options offer
PremiumCompany AnnouncementsAdAlta targets sophisticated investors with speculative ASX-listed options offer
3M ago
AdAlta files prospectus for options linked to A$2.5m placement to fund solid cancer immunotherapy push
Premium
Company Announcements
AdAlta files prospectus for options linked to A$2.5m placement to fund solid cancer immunotherapy push
3M ago
AdAlta hires cell therapy specialists to steer FDA path for mesothelioma CAR-T
Premium
Company Announcements
AdAlta hires cell therapy specialists to steer FDA path for mesothelioma CAR-T
3M ago
AdAlta launches “East-to-West” CAR-T strategy with promising mesothelioma data
PremiumCompany AnnouncementsAdAlta launches “East-to-West” CAR-T strategy with promising mesothelioma data
4M ago
AdAlta moves BZDS1901 CAR‑T manufacturing to Australia after promising mesothelioma data
Premium
Company Announcements
AdAlta moves BZDS1901 CAR‑T manufacturing to Australia after promising mesothelioma data
4M ago
AdAlta taps Oribiotech’s automated platform to scale CAR-T manufacturing in Asia-Pacific
Premium
Company Announcements
AdAlta taps Oribiotech’s automated platform to scale CAR-T manufacturing in Asia-Pacific
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100